Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Tinea corporis significantly reduces quality of life, so early detection and treatment are important.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Electrical impedance spectroscopy improves biopsy accuracy and efficiency for skin lesions.

NISCH syndrome is a rare genetic disorder affecting skin and liver, with variable symptoms and limited treatment options.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Lrig1 could be a marker for advanced sebaceous carcinoma.

c-Kit is important for heart regeneration and cancer development.

A rare biotin deficiency in an Iraqi family caused severe symptoms but was successfully treated with lifelong biotin.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

The document's conclusion cannot be provided because the document is not readable or understandable.

Ischemia-modified albumin can help diagnose ischemic conditions early, but better detection methods are needed.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

Clouston syndrome is inherited in an autosomal dominant pattern and caused by a specific gene mutation, with no current treatment available.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

The bio-based complex effectively repairs and protects chemically damaged hair.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

The research shows how certain drugs can form stable structures with polymers, which is important for making new pharmaceuticals.

Baricitinib was effective in treating both early and late onset alopecia areata.

The new method is rapid, sensitive, and accurate for evaluating the quality of the medicinal herb Platycladi cacumen.

SQSTM1 gene issues may increase the risk of alopecia areata.